PGAM5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.119600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.384850E-01
Normal-vs-Stage2
6.325800E-01
Normal-vs-Stage3
6.227600E-01
Normal-vs-Stage4
1.106360E-01
Stage1-vs-Stage2
2.577600E-01
Stage1-vs-Stage3
6.492000E-02
Stage1-vs-Stage4
5.981000E-01
Stage2-vs-Stage3
2.317000E-01
Stage2-vs-Stage4
1.615630E-01
Stage3-vs-Stage4
7.009800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.584200E-01
Normal-vs-AfricanAmerican
5.979800E-01
Normal-vs-Asian
4.030000E-01
Caucasian-vs-AfricanAmerican
9.202200E-01
Caucasian-vs-Asian
1.947540E-02
AfricanAmerican-vs-Asian
9.285900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.551600E-01
Normal-vs-Female
7.022800E-01
Male-vs-Female
2.669800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.090600E-01
Normal-vs-Age(41-60Yrs)
4.532000E-01
Normal-vs-Age(61-80Yrs)
7.213800E-01
Normal-vs-Age(81-100Yrs)
6.669800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.862000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.293400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.454600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.682980E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.258000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.177400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.791600E-01
Normal-vs-Daily Drinker
6.920600E-01
Normal-vs-Weekly Drinker
6.986000E-01
Normal-vs-Occasional Drinker
2.228200E-01
Normal-vs-Social Drinker
4.470200E-01
Non Drinker-vs-Daily Drinker
3.615000E-01
Non Drinker-vs-Weekly Drinker
4.422800E-01
Non Drinker-vs-Occasional Drinker
4.538200E-02
Non Drinker-vs-Social Drinker
1.775810E-01
Daily Drinker-vs-Weekly Drinker
9.451800E-01
Daily Drinker-vs-Occasional Drinker
4.312000E-01
Daily Drinker-vs-Social Drinker
7.501600E-01
Weekly Drinker-vs-Occasional Drinker
3.993000E-01
Weekly Drinker-vs-Social Drinker
6.949200E-01
Occasional Drinker-vs-Social Drinker
6.402000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.504200E-01
Normal-vs-Grade 2
8.839800E-01
Normal-vs-Grade 3
8.285600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.153600E-01
Grade 1-vs-Grade 3
3.566400E-01
Grade 1-vs-Grade 4
7.504200E-01
Grade 2-vs-Grade 3
2.782800E-01
Grade 2-vs-Grade 4
8.839800E-01
Grade 3-vs-Grade 4
8.285600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.991600E-01
Normal-vs-NonDiabetic
6.361600E-01
Diabetic-vs-NonDiabetic
4.936600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.326200E-01
Normal-vs-NoPancreatitis
6.540400E-01
Pancreatitis-vs-NoPancreatitis
9.790800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.531000E-01
Normal-vs-N1
6.106800E-01
N0-vs-N1
8.961400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.629800E-01
Normal-vs-TP53-NonMutant
5.935000E-01
TP53-Mutant-vs-TP53-NonMutant
2.286800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
